| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.6% | 0.0% |
| Div Cover | 6.4 | n/a |
| Op Mrgn | 7.8% | n/a |
| ROCE | 7.3% |
| Latest | F'cast | |
|---|---|---|
| P/E | 24.1 | n/a |
| PEG | 2.7 | n/a |
| Pr/Revenue | 0.6 | n/a |
| Pr/Book | 1.3 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 4.5% | n/a |
| PBT | -51.4% | n/a |
| EPS | 9.1% | n/a |
| DPS | -34.8% | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 1,106.20 | (1.90) | (7.10)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1,198.50 | 3.90 | 4.20p | 54.3 | n/a | n/a | 0.50p | 0.2% |
| 31-Dec-23 | 1,359.00 | 34.60 | 7.90p | 28.7 | 0.3 | +88% | 2.10p | 0.9% |
| 31-Dec-24 | 1,511.20 | 38.30 | 8.80p | 25.7 | 2.3 | +11% | 2.30p | 1.0% |
| 31-Dec-25 | 1,579.80 | 18.60 | 9.60p | 17.4 | 1.9 | +9% | 1.50p | 0.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Further extension of the PUSU Deadline | 04-Sep-2026 | 16:48 | RNS |
| Form 8.3 - Spire Healthcare Group plc | 04-Sep-2026 | 15:20 | RNS |
| Pentwater Capital Management LP - Form 8.3 - Spi... | 04-Sep-2026 | 15:20 | PR Newswire |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 238.00p |
| Change Today | -3.00p |
| % Change | -1.24 % |
| 52 Week High | 249.00 |
| 52 Week Low | 142.80 |
| Volume | 3,529,538 |
| Shares Issued | 402.76m |
| Market Cap | £958.57m |
| Beta | 0.01 |
| RiskGrade | 165 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 21-May-26 | 22-May-25 |
| Paid | 19-Jun-26 | 20-Jun-25 |
| Amount | 1.50p | 2.30p |
| Time | Volume / Share Price |
| 17:00 | 12,395 @ 242.00p |
| 16:37 | 2,685 @ 238.00p |
| 16:37 | 2,315 @ 238.00p |
| 16:35 | 52 @ 238.00p |
| 16:35 | 10,560 @ 238.00p |
| CEO | Justin Ash |
| CFO | Harbant Samra |
You are here: research